At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 277 enrolled
Drug / intervention
HTX-011B +4 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2, Randomized, Controlled Evaluation of the Efficacy and Safety of HTX-011 or HTX-002 for Post-Operative Analgesia Following Abdominoplasty Surgery
In Brief
A Phase 2 clinical trial evaluating HTX-011B, Placebo, and 3 other interventions for Postoperative Pain. Completed, enrolled 277 participants across 8 sites.
Detailed Summary
A Phase 2, Randomized, Controlled Evaluation of the Efficacy and Safety of HTX-011 or HTX-002 for Post-Operative Analgesia Following Abdominoplasty Surgery
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostoperative Pain
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20162017201820192020202120222023202420252026
First PostedFeb 2016
Enrollment StartFeb 2016
Primary CompletionMar 2017
Study CompletionApr 2017
TodayJul 2026
First PostedFeb 23, 2016
Enrollment StartFeb 23, 2016
Primary CompletionMar 1, 2017
Study CompletionApr 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 10.4 years ago
Interventions
HTX-011Bdrug
HTX- 011B (bupivacaine/meloxicam) via injection
Placebodrug
Saline placebo via injection
HTX-011Adrug
HTX- 011A (bupivacaine/meloxicam) via injection
HTX-002drug
HTX-002 via combination
Bupivicaine HCldrug
Bupivacaine HCl via injection